Show simple item record

dc.contributor.authorMkrtichyan, Mikayel
dc.contributor.authorChong, Namju
dc.contributor.authorAbu Eid, Rasha
dc.contributor.authorWallecha, Anu
dc.contributor.authorSingh, Reshma
dc.contributor.authorRothman, John
dc.contributor.authorKhleif, Samir N.
dc.date.accessioned2018-04-09T10:43:08Z
dc.date.available2018-04-09T10:43:08Z
dc.date.issued2013-08-29
dc.identifier.citationMkrtichyan , M , Chong , N , Abu Eid , R , Wallecha , A , Singh , R , Rothman , J & Khleif , S N 2013 , ' Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy ' , Journal for immunotherapy of cancer , vol. 1 , 15 , pp. 1-9 . https://doi.org/10.1186/2051-1426-1-15en
dc.identifier.issn2051-1426
dc.identifier.otherPURE: 72366643
dc.identifier.otherPURE UUID: 19ba9e42-ee3a-42ee-9d6a-fec47fbe1fef
dc.identifier.otherPubMed: 24829751
dc.identifier.otherPubMedCentral: PMC4019896
dc.identifier.otherScopus: 84991038640
dc.identifier.urihttp://hdl.handle.net/2164/10308
dc.identifier.urihttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4019896&tool=pmcentrez&rendertype=abstracten
dc.identifier.urihttp://www.mendeley.com/research/antipd1-antibody-significantly-increases-therapeutic-efficacy-listeria-monocytogenes-lmllo-immunotheen
dc.descriptionThis work was supported by the Intramural Research Program of the Center for Cancer Research, NCI, NIH, Georgia Regents University Cancer Center (GRUCC) and Advaxis Inc. RAE is supported by a Fellowship Grant from King Hussein Institute for Biotechnology and Cancer (KHIBC, Jordan).en
dc.format.extent9
dc.language.isoeng
dc.relation.ispartofJournal for immunotherapy of canceren
dc.rights© Mkrtichyan et al.; licensee BioMed Central Ltd. 2013 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectPD-1en
dc.subjectImmunotherapyen
dc.subjectListeria-based vaccineen
dc.subjectCombinational immunotherapyen
dc.subjectQR180 Immunologyen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subject.lccQR180en
dc.subject.lccRC0254en
dc.titleAnti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutrition, Institute of Education in Medical and Dental Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Dental Educationen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/2051-1426-1-15
dc.identifier.urlhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4019896&tool=pmcentrez&rendertype=abstracten
dc.identifier.urlhttp://www.mendeley.com/research/antipd1-antibody-significantly-increases-therapeutic-efficacy-listeria-monocytogenes-lmllo-immunotheen
dc.identifier.vol1en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record